New England Journal of Medicine · 1979 · 68 citations · 8 references
MedicinePharmacotherapySurgeryInterventional CardiologyRenal PathophysiologyVascular SurgeryBalloon AngioplastyBlood Pressure ManagementHypertension ManagementHypertension PharmacotherapyRenal Artery DiseaseRenal Vascular DiseaseBilateral Renovascular DiseaseDrug-related Side EffectsRenal Artery AngioplastyRenal Vascular Surgery
RENAL vascular surgery and pharmacotherapy are the are the two modalities currently employed, singly or in combination, in the management of renovascular hypertension.1 2 3 Although both methods have been used successfully in the treatment of this disorder, both have substantial drawbacks. Renovascular operations carry a consequential operative risk, have a substantial failure rate and are expensive.1 2 3 4 5 6 Furthermore, the suitability of this method of treating renovascular disease is clearly limited by the usually progressive and frequently bilateral nature of the dis-, order.1 , 2 On the other hand, pharmacotherapy of renovascular hypertension has such disadvantages as poor compliance, drug side effects and a sizable . . .
8
Transluminal Treatment of Arteriosclerotic Obstruction
Charles T. Dotter, Melvin P. Judkins · Circulation · 1964 · 1.8K citations · Full text
A Grüntzig, W. Vetter, Bernhard Meier et al. · The Lancet · 1978 · 492 citations
Medicine, Cardiology, Nephrology +12
Pathologic classification of renal arterial disease in renovascular hypertension.
Harrison Eg, McCormack Lj · PubMed · 1971 · 430 citations
Medicine, Nephrology, Pathology +15
Barbara J. McNeil, Paul D. Varady, Belton A. Burrows et al. · New England Journal of Medicine · 1975 · 180 citations
Medicine, Cardiology, Surgery +16